Radiolabeled Compounds in Diagnosis of Infectious and Inflammatory Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|24|2935-2950

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.24, 2004-09, pp. : 2935-2950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiolabeled Compounds in the Development of Cytotoxic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2923-2934

Bentham Science Publishers

Access to resources Recommend Favorite

How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease

By  

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 198-218

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radiolabeled Compounds for Myocardial Perfusion Imaging

By  

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1041-1057

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Biomarkers in Peripheral Artery Disease: Diagnosis, Prognosis, and Therapeutic Challenges

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2744-2753

Bentham Science Publishers

Access to resources Recommend Favorite

Periodontitis and Periodontal Disease - Innovative Strategies for Reversing the Chronic Infectious and Inflammatory Condition by Natural Products

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 230-237

Bentham Science Publishers

Access to resources Recommend Favorite